)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Maravai LifeSciences (MRVI) investor relations material
Maravai LifeSciences Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary11 Aug, 2025
Executive summary
New CEO and CFO appointed in June 2025, initiating a comprehensive restructuring and cost reduction plan targeting over $50M in annualized savings and a 25% workforce reduction, with a focus on operational discipline, business diversification, and restoring profitability by the second half of 2026.
Revenue declined 31.7% year-over-year to $47.4M in Q2 2025, mainly due to the absence of high-volume CleanCap sales for commercial vaccine programs.
Major restructuring includes headcount and expense reductions, with most actions completed by year-end and full impact expected in 2026.
Two acquisitions completed in H1 2025 (Molecular Assemblies and Officinae Bio) expanded product offerings and technology capabilities.
Launch of new e-commerce platform, AI-driven mRNA builder tool, and expanded CDMO strategy with a CleanCap license and supply agreement.
Financial highlights
Q2 2025 revenue was $47.4M, down from $69.4M in Q2 2024; Nucleic Acid Production (NAP) at $31.1M (down 43.1%), Biologics Safety Testing (BST) at $16.3M (up 9.9%).
GAAP net loss was $69.8M, including a $30.4M goodwill impairment charge; adjusted EBITDA was negative $10.4M.
Gross margin fell to 16.4% in Q2 2025 from 44.4% in Q2 2024.
Cash and cash equivalents at quarter-end were $270M, with long-term debt of $297M.
Adjusted net loss per share was $(0.08); GAAP net loss per share was $(0.27).
Outlook and guidance
Guidance for 2025 has been withdrawn pending a comprehensive business review; no high-volume CleanCap orders expected for the remainder of 2025.
Leadership targets positive adjusted EBITDA and free cash flow by the second half of 2026, independent of CleanCap upside.
Management anticipates lower operating and R&D expenses due to cost-saving initiatives.
How will centralized TriLink R&D oversight impact innovation?
What's the expected growth rate for the BST business?
How will e-commerce investments drive research revenue?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Maravai LifeSciences earnings date
Q3 20256 Nov, 2025
Next Maravai LifeSciences earnings date
Q3 20256 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Maravai LifeSciences Holdings, Inc. is a life sciences company providing products for research and development of drug therapies to enable the discovery, development, manufacture and commercialization of novel vaccines, therapeutics and diagnostic tests. The company's main offerings includes innovative and cost-effective products, technologies and services to the biopharmaceutical, vaccine and other healthcare industries. From small molecule development through to cell culture process development, Maravai offers a wide range of enzyme-linked immunoassay (ELISA) reagents for diagnostics development, safety testing and commercial production. Maravai's customers include market-leading companies - to which they sell proprietary technologies that enables rapid development of drug therapies, including antibody-based therapeutics, globally. Maravai LifeSciences Holdings, Inc. was founded in 2014 and is headquartered in San Diego, California.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage